10/17/2024
3:54 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 15-12G | |
10/04/2024
3:21 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:24 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:27 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:30 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:33 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:36 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:18 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form S-8 POS | |
10/04/2024
3:16 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form POSASR | |
08/27/2024
9:14 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
Get the Latest News and Ratings for MPSYF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024
3:51 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC 14D9/A | |
08/07/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024
7:14 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:05 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024
10:25 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024
3:20 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:48 AM | MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC 14D9 | |
07/05/2024
5:02 AM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024
9:18 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024
9:07 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:41 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:33 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC14D9C | |
06/20/2024
2:38 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024
11:06 AM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC 13G/A | |
06/10/2024
10:01 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024
3:36 PM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024
9:22 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos |
06/04/2024
9:17 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
9:17 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
9:17 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024
9:16 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024
9:13 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
1:19 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC 14D9/A | |
05/23/2024
9:11 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
8:04 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
9:07 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024
9:15 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
3:43 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
| Form SC 14D9/A | |
05/16/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024
9:11 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024
9:09 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024
9:27 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
9:19 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024
9:31 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024
9:08 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024
3:45 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024
9:24 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys (Subject)
NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024
9:07 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024
9:29 AM | MorphoSys AG (Filer)
MorphoSys (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy MPSYF Stock Free MPSYF Stock Alerts